Nilo Therapeutics is a biotechnology company focused on developing innovative medicines that leverage neural circuits to restore immune homeostasis in diseases. By targeting central brain-body circuits that regulate systemic inflammation, Nilo offers a unique approach to immunomodulation, aiming to address a wide range of autoimmune and inflammatory diseases with significant unmet needs. The company is headquartered in New York, NY.